ArticleInfectious Disease Modelling2026
Within host dynamics of HPV infection with cellular immunity and HPV-infected dormant cells reactivation.
Article in Infectious Disease Modelling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Like other viruses, human papillomavirus genotypes can remain dormant for years or decades and later reactivate due to some well-known factors. The activation of such a dormant infection years later can cause many health and behavioural problems at the individual and societal levels, respectively. From a personalised health perspective, reactivation of a dormant HPV, especially high-risk genotypes such as HPV 16 or 18 can worsen the health condition of the infected person, should they be (or happen to be newly) infected with a different HPV genotype. However, detailed mechanisms that impact the health outcome of an infected person due to rebounding dormant HPV have not been mathematically investigated. The core of this paper is to study the dynamics of an in-host high-risk HPV infection, taking into account cell-mediated immunity and the consequences of reactivation of HPV-infected dormant cells using compartmental modelling. The local and global stabilities of the equilibria are established using Lyapunov and LaSalle techniques, and the bifurcation analysis is performed. Compared to the model without the provision of virus particles due to the reactivation of infected dormant cells, our results suggest that such reactivation can exacerbate the health condition of an infected person by promoting the persistence of infection, which further weakens the active immune response and favours the progression of infection to HPV-induced cancers. In addition, we provide the sensitivity analysis of threshold parameters, state variables with respect to model parameters, and numerical simulations are used to illustrate the theoretical results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.